June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
From 'good fat' to beta cell breakthroughs: Diabetes experts present research at ADA Conference
June 14, 2019 | Letisia Marquez
City of Hope's Bart Roep, Ph.D., City of Hope’s Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes, was invited to speak at the American Diabetes Association’s 79th Scientific Sessions, held June 7-11, 2019 in San Francisco. Roep and several City of Hope colleagues highlighted research successes and presented recent findings.
Study by diabetes expert describes promising type 1 treatments
February 14, 2019 | Katie Neith
A paper co-authored by Bart Roep, Ph.D., Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology at City of Hope, published in Nature explores new ways of replacing beta cells after too many of them have been killed by the immune system.
Researchers identify new target for potential type 1 diabetes treatment
October 18, 2018 | Katie Neith
Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.
Stem Cell Transplants Lead to Cure for Some Type 1 Diabetes Patients
March 1, 2017 | Katie Neith
A recent clinical trial monitored by City of Hope’s Bart Roep, Ph.D., showed promising results for a possible cure of type 1 diabetes (T1D). Although the study involved risky stem cell transplant procedures, it identified new paths for personalized therapies of T1D.
New Study Flips the Script on Cause of Type 1 Diabetes
February 27, 2017 | Katie Neith
For decades, scientists believed that the root cause of type 1 diabetes (T1D) was the immune system mistakenly identifying insulin secreting beta cells as a potential danger and, in turn, destroying them. Now, a study led by City of Hope’s Bart Roep turns that idea on its head.
‘Hidden History’: Legacy of Diabetes Care at City of Hope
January 25, 2017 | Katie Neith
City of Hope — widely known as a center for cancer care and research — is also the home of one of the most influential diabetes research programs in the world.
The Future of Diabetes: A Focus on Personalized Care
January 16, 2017 | Katie Neith
Diabetes affects over 422 million people worldwide according to the World Health Organization, but no two patients are alike. So in 2017 and beyond, treatments will increasingly make use of precision medicine to personalize treatment options. At City of Hope, researchers are combining the forces of a transformative gift with new resources to speed these treatments to patients.